Imjudo 25mg (Tremelimumab-Actl Vials) 25mg/1.25ml ( 20mg/ml)

Imjudo 25mg (Tremelimumab-Actl) is a prescription medication supplied as 25mg/1.25ml vials for intravenous use. Store between 2–8°C and protect from light. This page provides neutral, factual details about uses, handling, and safety notes for catalog reference.

Strength

25mg/1.25ml ( 20mg/ml)

Pack Size

Storage

2-8°

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Imjudo 25mg (Tremelimumab-Actl) is used in combination with other therapies for certain types of cancer treatment. It belongs to a class of drugs that help the immune system recognize and attack cancer cells. This medication is typically administered in clinical settings under professional supervision. Patients often ask, 'what is Imjudo 25mg used for' in cancer therapy protocols.

Side Effects

Imjudo 25mg may cause immune-related effects as the body’s immune response adjusts. Common effects can include fatigue, skin reactions, or gastrointestinal changes. These effects vary by individual and are monitored during treatment. Patients may experience symptoms that differ from typical medication side effects.

Precautions & Warnings

Imjudo 25mg requires refrigeration between 2–8°C and protection from light. It should be handled by healthcare professionals in sterile conditions. Patients should inform their provider of all medications and medical history before use. Avoid exposure to extreme temperatures during transport or storage.

Avoid Interactions

Imjudo 25mg may interact with other immune-modulating therapies or medications that affect the immune system. Concomitant use of corticosteroids or immunosuppressants can alter its effects. Alcohol and certain supplements may also influence treatment outcomes. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Imjudo 25mg (Tremelimumab-Actl) is used in combination with other therapies for certain types of cancer treatment.

Imjudo 25mg is administered intravenously by healthcare professionals in a clinical setting.

Common effects may include fatigue, skin reactions, or gastrointestinal changes, varying by individual.

No, Imjudo 25mg must be refrigerated between 2–8°C and protected from light.

Yes, it may interact with other immune-modulating therapies or medications affecting the immune system.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.